Multilocus sequence typing and ftsI sequencing: A powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Skaare, Dagfinn ^a,b   Anthonisen, Inger Lill ^a   Caugant, Dominique A ^c,d   Jenkins, Andrew ^e   Steinbakk, Martin ^c   Strand, Linda ^f   Sundsfjord, Arnfinn ^b   Tveten, Yngvar ^f   Kristiansen, Bjørn Erik ^b  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^f TELEMARK HOSPITAL   (Norway)

Author keywords

Beta lactam resistance; BLNAR; ftsI; Haemophilus influenzae; Horizontal gene transfer; MLST; PBP3; PFGE; Recombination; Surveillance

Indexed keywords

AMPICILLIN; CEFOTAXIME; MEROPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 3; PENICILLIN BINDING PROTEIN 3 TYPE A; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITALIZATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; NORWAY; NUCLEOTIDE SEQUENCE; AGED; CLASSIFICATION; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HORIZONTAL GENE TRANSFER; HUMAN; INFANT; JAPAN; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY;

HAEMOPHILUS INFLUENZAE;

AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; GENE TRANSFER, HORIZONTAL; GENETIC VARIATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NORWAY; PENICILLIN-BINDING PROTEINS;

EID: 84901769411     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-131     Document Type: Article

References (53)

1. Haemophilus influenzae: Then and now. Jordens JZ, Slack MPE, Eur J Clin Microbiol Infect Dis 1995 14 935 948 10.1007/BF01691374 8654443
2. Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada. Sill ML, Tsang RSW, Antimicrob Agents Chemother 2008 52 1551 1552 10.1128/AAC.01580-07 18227189
3. Invasive Haemophilus influenzae in British Columbia: non-Hib and non-typeable strains causing disease in children and adults. Shuel M, Hoang L, Law DKS, Tsang R, Int J Infect Dis 2011 15 167 e173 10.1016/j.ijid.2010.10.005 21134777
4. Increase of beta-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010. Resman F, Ristovski M, Forsgren A, Kaijser B, Kronvall G, Medstrand P, Melander E, Odenholt I, Riesbeck K, Antimicrob Agents Chemother 2012 56 4408 4415 10.1128/AAC.00415-12 22687505
5. Current and future prospects for a vaccine for nontypeable Haemophilus influenzae. Murphy T, Curr Infect Dis Rep 2009 11 177 182 10.1007/s11908-009- 0027-1 19366559
6. Antimicrobial resistance in Haemophilus influenzae. Tristram S, Jacobs MR, Appelbaum PC, Clin Microbiol Rev 2007 20 368 389 10.1128/CMR.00040-06 17428889
7. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M, Antimicrob Agents Chemother 2001 45 1693 1699 10.1128/AAC.45.6.1693-1699.2001 11353613
8. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Hasegawa K, Chiba N, Kobayashi R, Murayama SY, Iwata S, Sunakawa K, Ubukata K, Antimicrob Agents Chemother 2004 48 1509 1514 10.1128/AAC.48.5.1509-1514.2004 15105098
9. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Garcia-Cobos S, Campos J, Lazaro E, Roman F, Cercenado E, Garcia-Rey C, Perez-Vazquez M, Oteo J, de AF, Antimicrob Agents Chemother 2007 51 2564 2573 10.1128/AAC.00354-07 17470649
10. Genetic characteristics and clonal dissemination of beta-lactamase non-producing ampicillin-resistant (BLNAR) Haemophilus influenzae isolated from the upper respiratory tract in Japan. Hotomi M, Fujihara K, Billal DS, Suzuki K, Nishimura T, Baba S, Yamanaka N, Antimicrob Agents Chemother 2007 51 3969 3976 10.1128/AAC.00422-07 17698631
11. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. Skaare D, Allum AG, Anthonisen IL, Jenkins A, Lia A, Strand L, Tveten Y, Kristiansen BE, Clin Microbiol Infect 2010 16 1117 1124 19737286
12. Canadian beta-lactamase negative Haemophilus influenzae isolates showing decreased susceptibility toward ampicillin have significant penicillin binding protein 3 mutations. Shuel ML, Tsang RSW, Diagn Microbiol Infect Dis 2009 63 379 383 10.1016/j.diagmicrobio.2008.12.015 19249177
13. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. Ubukata K, J Infect Chemother 2003 9 285 291 10.1007/s10156-003-0278-Y 14691647
14. Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis. Dabernat H, Delmas C, Eur J Clin Microbiol Infect Dis 2012 31 2745 2753 10.1007/s10096-012-1623-9 22538797
15. Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. Ubukata K, Chiba N, Morozumi M, Iwata S, Sunakawa K, J Infect Chemother 2013 19 34 41 10.1007/s10156-012-0448-x 22806445
16. Genetic diversity of the ftsI gene in beta-lactamase-nonproducing ampicillin-resistant and beta-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea. Park C, Kim KH, Shin NY, Byun JH, Kwon EY, Lee JW, Kwon HJ, Choi EY, Lee DG, Sohn WY, Kang JH, Microb Drug Resist 2013 19 224 230 10.1089/mdr.2012.0116 23308379
17. Antimicrobial resistance genotype trend and its association with host clinical characteristics in respiratory isolates of Haemophilus influenzae. Hagiwara E, Baba T, Shinohara T, Nishihira R, Komatsu S, Ogura T, Chemotherapy 2012 58 352 357 10.1159/000343973 23183338
18. Polymorphism in ftsI gene and beta-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. Barbosa AR, Giufre M, Cerquetti M, Bajanca-Lavado MP, J Antimicrob Chemother 2011 66 788 796 10.1093/jac/dkq533 21393206
19. Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M, Antimicrob Agents Chemother 2004 48 1630 1639 10.1128/AAC.48.5.1630-1639.2004 15105114
20. Prevalence and genotypic characteristics of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae in Australia. Witherden EA, Montgomery J, Henderson B, Tristram SG, J Antimicrob Chemother 2011 66 1013 1015 10.1093/jac/dkr035 21393186
21. Genotypic versus phenotypic characterization, with respect to beta-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to beta-lactam resistance markers. Sevillano D, Giménez MJ, Cercenado E, Cafini F, Gené A, Alou L, Marco F, Martinez-Martinez L, Coronel P, Aguilar L, Antimicrob Agents Chemother 2009 53 267 270 10.1128/AAC.00402-08 18955529
22. Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, Kang Y, Antimicrob Agents Chemother 2010 54 65 71 10.1128/AAC.00966-09 19884366
23. Characteristics of Haemophilus influenzae invasive isolates from Portugal following routine childhood vaccination against H. influenzae serotype b (2002-2010). Bajanca-Lavado MP, Simoes AS, Betencourt CR, Sa-Leao R, Eur J Clin Microbiol Infect Dis 2014 33 603 610 10.1007/s10096-013-1994-6 24154654
24. Isolates of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem. Garcia-Cobos S, Arroyo M, Perez-Vazquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J, J Antimicrob Chemother 2014 69 111 116 10.1093/jac/dkt324 23943391
25. Molecular epidemiology of nontypeable Haemophilus influenzae causing community-acquired pneumonia in adults. Puig C, Calatayud L, Marti S, Tubau F, Garcia-Vidal C, Carratala J, Linares J, Ardanuy C, PLoS One 2013 8 82515 10.1371/journal.pone.0082515 24349303
26. Horizontal gene transfer of ftsI, the gene encoding penicillin-binding protein 3, in Haemophilus influenzae. Takahata S, Ida T, Senju N, Sanbongi Y, Miyata A, Maebashi K, Hoshiko S, Antimicrob Agents Chemother 2007 51 1589 1595 10.1128/AAC.01545-06 17325223
27. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Sanbongi Y, Suzuki T, Osaki Y, Senju N, Ida T, Ubukata K, Antimicrob Agents Chemother 2006 50 2487 2492 10.1128/AAC.01316-05 16801430
28. Role of inter-species recombination of the ftsI gene in the dissemination of altered penicillin-binding-protein-3-mediated resistance in Haemophilus influenzae and Haemophilus haemolyticus. Witherden EA, Bajanca-Lavado MP, Tristram SG, Nunes A, J Antimicrob Chemother 2014 69 1501 1509 10.1093/jac/dku022 24562614
29. Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, Heuberger S, Krizova P, Olcen P, Slack M, Taha MK, Maiden MCJ, Microbiology 2011 157 2181 2195 10.1099/mic.0.050518-0 21622526
30. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, Popovic T, Spratt BG, J Clin Microbiol 2003 41 1623 1636 10.1128/JCM.41.4.1623-1636.2003 12682154
31. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG, J Bacteriol 2004 186 1518 1530 10.1128/JB.186.5.1518-1530.2004 14973027
32. Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing. Erwin AL, Sandstedt SA, Bonthuis PJ, Geelhood JL, Nelson KL, Unrath WCT, Diggle MA, Theodore MJ, Pleatman CR, Mothershed EA, Sacchi CT, Mayer LW, Gilsdorf JR, Smith AL, J Bacteriol 2008 190 1473 1483 10.1128/JB.01207-07 18065541
33. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo, Norway. NORM/NORM-VET 2007, 2008 http://www.unn.no/getfile.php/UNN%20INTER/Fagfolk/www.antibiotikaresistens.no/ NORM%202008/NORM%20NORM-VET%202007.pdf
34. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. Stralin K, Backman A, Holmberg H, Fredlund H, Olcen P, APMIS 2005 113 99 111 10.1111/j.1600-0463.2005.apm1130203.x 15723684
35. PCR for capsular typing of Haemophilus influenzae. Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS, Moxon ER, J Clin Microbiol 1994 32 2382 2386 7814470
36. Performance standards for antimicrobial susceptibility testing, twenty-third informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, 2013
37. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014 http://www.eucast.org
38. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C, Antimicrob Agents Chemother 2002 46 2208 2218 10.1128/AAC.46.7.2208-2218.2002 12069976
39. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B, J Clin Microbiol 1995 33 2233 2239 7494007
40. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo, Norway. NORM/NORM-VET 2011, 2012 http://www.unn.no/getfile.php/UNN%20INTER/Fagfolk/www.antibiotikaresistens.no/ NORM%202012/NORM%20NORM-VET%202011.pdf
41. Årsrapport 2012 for sykdomsprogrammet Invasive sykdommer. Oslo, Norway. Norwegian Institute of Public Health, 2013 http://www.fhi.no/dokumenter/ 045999cadf.pdf
42. Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006. Sill ML, Law DKS, Zhou J, Skinner S, Wylie J, Tsang RSW, FEMS Immun & Med Microbiol 2007 51 270 276 10.1111/j.1574-695X.2007.00299.x
43. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children. Sunakawa K, Farrell DJ, Ann Clin Microbiol Antimicrob 2007 6 7 10.1186/1476-0711-6-7 17697316
44. Nontypeable Haemophilus influenzae meningitis in children: phenotypic and genotypic characterization of isolates. Cardines R, Giufre M, Mastrantonio P, Gli Atti ML, Cerquetti M, Pediatr Infect Dis J 2007 26 577 582 10.1097/INF.0b013e3180616715 17596797
45. Genotyping of Haemophilus influenzae type b in pre-vaccination era. Otsuka T, Komiyama K, Yoshida K, Ishikawa Y, Zaraket H, Fujii K, Okazaki M, J Infect Chemother 2012 18 213 218 10.1007/s10156-011-0323-1 22038124
46. Multilocus sequence typing and pulsed field gel electrophoresis of otitis media causing pathogens. Thomas J, Pettigrew M, Auditory and Vestibular Research New York: Humana Press, Sokolowski B, 493 2009 179 190
47. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Osaki Y, Sanbongi Y, Ishikawa M, Kataoka H, Suzuki T, Maeda K, Ida T, Antimicrob Agents Chemother 2005 49 2834 2839 10.1128/AAC.49.7.2834-2839.2005 15980357
48. Extensive variation in natural competence in Haemophilus influenzae. Maughan H, Redfield RJ, Evolution 2009 63 1852 1866 10.1111/j.1558-5646.2009. 00658.x 19239488
49. Transformation of natural genetic variation into Haemophilus influenzae genomes. Mell JC, Shumilina S, Hall IM, Redfield RJ, PLoS Pathog 2011 7 1002151 10.1371/journal.ppat.1002151 21829353
50. Investigations into genome diversity of Haemophilus influenzae using whole genome sequencing of clinical isolates and laboratory transformants. Power P, Bentley S, Parkhill J, Moxon E, Hood D, BMC Microbiol 2012 12 273 10.1186/1471-2180-12-273 23176117
51. An amino acid substitution in PBP-3 in Haemophilus influenzae associate with the invasion to bronchial epithelial cells. Okabe T, Yamazaki Y, Shiotani M, Suzuki T, Shiohara M, Kasuga E, Notake S, Yanagisawa H, Microbiol Res 2010 165 11 20 10.1016/j.micres.2008.03.003 18417334
52. A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease. Murphy TF, Lesse AJ, Kirkham C, Zhong H, Sethi S, Munson RS, PLoS One 2011 6 25923 10.1371/journal.pone.0025923 21998721
53. Population structure in nontypeable Haemophilus influenzae. LaCross NC, Marrs CF, Gilsdorf JR, Infect Genet Evol 2013 14 125 136 23266487